Primary liver cancer
Conditions
Interventions
Trial Group:TACE combine with Jiedu recipe
Sponsors
Shanghai Changhai Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients with primary liver cancer diagnosed according to the diagnostic and therapeutic specifications for primary liver cancer (2019 Edition) are classified as stage B in Barcelona; (2) Patients should not receive any Chinese herbal medicine and systemic treatment in the past two weeks; (3) ECoG (Eastern Cooperative Oncology Group) score 0-1; (4) Compensatory liver function, or child Pugh grade A or B; (5) Patients need a life expectancy of at least 3 months; (6) Voluntarily accept the treatment of this study protocol and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Taking drugs that may affect the evaluation observation indexes during the trial; (2) The child Pugh score of liver function was grade C; (3) WBC < 2.0 × 10 ^ 9 / L, platelet < 30 × 10^9/L (4) Tumors accounted for more than 70% of the whole liver; (5) Patients with serious primary diseases such as cardio cerebrovascular, liver, kidney and hematopoietic system and psychosis; (6) Those who fail to take drugs according to the regulations after informed consent, cannot judge the curative effect, or incomplete data affect the judgment of curative effect.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PFS; | — |
Countries
China
Contacts
Public ContactShufang Liang
Outcome results
None listed